Meet the Researcher: Nathaniel Hogrebe

Nathaniel Hogrebe, PhD has always had an interest in science, and now, as a junior faculty member in the Millman Lab, he has steadily built a career as a leader in diabetes research, working closely with Dr. Millman to pioneer cutting-edge research in stem cell-derived islets (SC-islets). Throughout his education, Dr. Hogrebe knew that rather […]

Jones emphasizes patient awareness with weight-loss drugs in AP interview 

On January 30, the Associated Press Newsroom released an editorial video titled “About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds,” featuring Kai Jones, MD. Dr. Jones is an Assistant Professor of Medicine for WashU Medicine’s Division of Endocrinology, Metabolism and Lipid Research.   The editorial discusses the results of […]

Molecular analysis of isthmus thyroid nodules and carcinomas

On November 11, Sina Jasim, MD, MPH; Allan Golding, MD; David Bimston, MD; Yang Chen, PhD; Ruochen Jiang, PhD; Yangyang Hao, PhD; Jing Huang, PhD; Joshua P. Klopper, MD; Richard T. Kloos, MD; and Taylor C. Brown, MD, MHS had their research article titled “Cytologic and Molecular Assessment of Isthmus Thyroid Nodules and Carcinomas,” published […]

Bourey defines barriers in sleep medicine and weight management

On October 4, the American Academy of Sleep Medicine published an article titled “How weight loss medications are changing the sleep field,” featuring an interview with  Raymond E. Bourey, MD, FAASM. Dr. Bourey has board certification, 25 years in sleep medicine, and is an Associate Professor of Medicine with WashU Medicine’s Division of Endocrinology, Metabolism […]

Meet the Researcher: Matthew Ishahak

In a recent publication from the Millman Lab titled “Genetically Engineered Brain Organoids Recapitulate Spatial and Developmental States of Glioblastoma Progression,” Dr. Matthew Ishahak and colleagues developed engineered glioblastoma brain organoids (eGBOs) to investigate tumor progression in glioblastoma (GBM), an aggressive form of brain cancer that is highly resistant to therapy. The study, published in […]

Inaugural Repa-Eschen Lecture 

On Thursday, December 19, Washington University’s John T. Milliken Department of Medicine hosted their Medicine Grand Rounds event series at the Clopton Auditorium. During which the first-ever Repa-Eschen Lecture took place with presenting speaker Clay F. Semenkovich, MD, Chief of the Division of Endocrinology, Metabolism and Lipid Research, Irene E. and Michael M. Karl Professor of […]